Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 28/10/2026			5-day change	1st Jan Change
14.49 ^MXN	-6.03%		+0.76%	-19.01%

10-23	Genomma Lab Internacional, S.A.B. de C.V., Q3 2026 Earnings Call, Oct 22, 2026
10-21	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	14,104	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-19.28%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	18,295	17,770	17,337
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-17.75%	-2.87%	-2.44%
P/E	14.9x	12x	13.1x	11.7x	11.1x	7.45x	7.34x	6.57x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	1x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.4x	4.87x	0.6x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.79x	0.75x	0.71x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	1.03x	0.95x	0.87x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.5x	4.15x	3.8x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.94x	4.57x	4.18x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	12.7x	8.92x	8.07x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	7.86%	11.2%	12.4%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8003	1.071	1.441
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	5.52%	7.39%	9.94%
EPS ²	1.44	1.41	1.08	2.14	1.61	1.946	1.975	2.206
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	41.1%	54.2%	65.3%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	17,805	18,740	19,945
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,061	4,279	4,559
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,705	3,886	4,146
Net income ¹	1,451	1,397	1,031	2,137	1,607	1,951	2,058	2,285
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,190	3,666	3,233
Reference price ²	21.48	16.94	14.16	25.13	17.89	14.49	14.49	14.49
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	973,386	-	-
Announcement Date	23/2/22	22/2/23	21/2/24	26/2/25	25/2/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	7.45x	1.03x	4.5x	5.52%	756M
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	27.35x	6.50x	17.41x	2.45%	403.79B
Weighted average by Cap.	35.28x	8.40x	20.63x	1.79%